Physician profile
Andreas Antono
NPI 1386105104
$2,529.17
in general payments reported to CMS, 2019-2025
11 companies · $1,307 in 2025
The $1,307 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $35.37 · 2024: $1,187 · 2025: $1,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,766 · Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,766.24 |
| Food and Beverage | $762.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,142.28 | 2024-2025 | |
| Biogen, INC. | $103.61 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $64.16 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $54.78 | 2023-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Pfizer INC. | $37.51 | 2024 | |
| Abbvie INC. | $32.65 | 2023-2024 | Liletta |
| Exact Sciences Corporation | $31.92 | 2025 | The Cologuard Plus Collection Kit |
| Millicent US INC | $23.73 | 2025 | Femring, Intrarosa |
| Sumitomo Pharma America, INC. | $16.70 | 2025 | Myfembree |
| Organon LLC | $12.80 | 2024 | |
| Mayne Pharma Commercial LLC | $9.03 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreas Antono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.